MoonLake Immunotherapeuti Stock Forward View - Relative Strength Index
| MLTX Stock | USD 17.13 0.10 0.59% |
Momentum
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter -0.90 | EPS Estimate Current Year -3.76 | EPS Estimate Next Year -3.74 | Wall Street Target Price 23.8571 | EPS Estimate Current Quarter -0.94 |
This section frames MoonLake Immunotherapeutics response to recent headlines in a peer context. Sentiment context here is built from MoonLake Immunotherapeuti's options activity and short interest data.
Short Interest Map for MoonLake Immunotherapeuti
MoonLake Immunotherapeuti's short interest, when combined with volume and price trend analysis, helps investors assess whether selling pressure in MoonLake is likely to persist or abate.
200 Day MA 29.6345 | Short Percent 0.1926 | Short Ratio 5.19 | Shares Short Prior Month 7.3 M | 50 Day MA 16.3736 |
MoonLake RSI Indicator
Hype-Price Trend View - MoonLake Immunotherapeuti
MoonLake Immunotherapeuti's market sentiment is a measurable proxy for investor optimism or fear. Monitoring changes in sentiment trend alongside price data gives early warning of potential reversals in MoonLake.
For MoonLake Immunotherapeuti, sentiment-adjusted positioning means sizing exposure relative to how extreme the current market mood has become. High positive sentiment with elevated valuation is a classic signal to reduce risk.
MoonLake Immunotherapeuti Implied Volatility | 1.28 |
For long-term investors in MoonLake Immunotherapeuti, monitoring MoonLake Immunotherapeuti's implied volatility helps assess whether hedging costs are reasonable and whether the options market is pricing in unusually high uncertainty.
MoonLake Immunotherapeuti after-hype prediction price | $ 17.09 |
This view helps relate attention signals to forecasting and technical indicators plus earnings context.
Historical Fundamental Analysis of MoonLake Immunotherapeuti provides a cross-check on projections for MoonLake Immunotherapeuti. The analysis adds historical context for the projection set.Rule 16 Summary for current MoonLake contract - Market Context
Rule 16 converts implied volatility into an estimated daily move of about 0.08% for 2026-05-15 options. At a recent price around $ 17.13, the implied daily move is approximately $ 0.0137 , which is informational only.
Open Interest Coverage for 2026-05-15 MoonLake Option Contracts
Outstanding MoonLake Immunotherapeuti options are captured via open interest, which provides contract-flow context.
MoonLake Immunotherapeuti Additional Predictive Modules
Most predictive techniques to examine MoonLake price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for MoonLake using various technical indicators. When you analyze MoonLake charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check MoonLake Immunotherapeuti Volatility | Backtest MoonLake Immunotherapeuti | Information Ratio |
MoonLake Immunotherapeuti Trading Date Momentum
| On March 15 2026 MoonLake Immunotherapeutics was traded for 17.13 at the closing time. The top price for the day was 17.79 and the lowest listed price was 17.06 . There was no trading activity during the period 0.0. Lack of trading volume on March 15, 2026 did not cause price change. The trading delta at closing time against the current closing price is 0.06% . |
| Compare MoonLake Immunotherapeuti to competition |
Other Forecasting Options for MoonLake Immunotherapeuti
The price trajectory of MoonLake is the primary concern for any investor assessing it as an opportunity. MoonLake Stock price charts are filled with noise that can easily mislead uninformed investment decisions.MoonLake Immunotherapeuti Related Equities
The following equities are related to MoonLake Immunotherapeuti within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing MoonLake Immunotherapeuti against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
MoonLake Immunotherapeuti Market Strength Events
Understanding the market strength of MoonLake Immunotherapeuti stock enables investors to assess the security's momentum and responsiveness to broader market forces. These indicators are essential tools for timing trades in MoonLake Immunotherapeutics with greater precision.
MoonLake Immunotherapeuti Risk Indicators
Reviewing MoonLake Immunotherapeuti's basic risk indicators is essential for investors who want to forecast its price and manage their investment risk effectively. This analysis helps identify the amount of risk involved in holding MoonLake Immunotherapeuti's and informs decisions about hedging and position.
| Mean Deviation | 3.32 | |||
| Semi Deviation | 3.55 | |||
| Standard Deviation | 6.01 | |||
| Variance | 36.1 | |||
| Downside Variance | 15.48 | |||
| Semi Variance | 12.61 | |||
| Expected Short fall | -3.75 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for MoonLake Immunotherapeuti
Coverage intensity for MoonLake Immunotherapeutics matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Contributor Headline
Latest Perspective From Macroaxis
MoonLake Immunotherapeuti Short Properties
Short sentiment tied to MoonLake Immunotherapeutics matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 64.5 M | |
| Cash And Short Term Investments | 394 M |
More Resources for MoonLake Stock Analysis
A structured review of MoonLake Immunotherapeuti often starts with core financial statements and trend context. Key ratios help frame profitability, efficiency, and growth context for MoonLake Immunotherapeutics Stock. Highlighted below are reports that provide context for MoonLake Immunotherapeutics Stock:Historical Fundamental Analysis of MoonLake Immunotherapeuti provides a cross-check on projections for MoonLake Immunotherapeuti. The analysis adds historical context for the projection set. Analysis related to MoonLake Immunotherapeuti should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Market capitalization and book value offer complementary views of MoonLake Immunotherapeuti — the first driven by investor sentiment, the second by accounting standards. MoonLake Immunotherapeuti's market capitalization is 1.23 B. With a P/B ratio of 4.04, the market values MoonLake Immunotherapeuti well above its book equity. Enterprise value stands at 910.44 M. Intrinsic value represents an estimate of underlying worth and can differ from both market price and book value. Valuation methods compare these perspectives to frame context.
Value and price for MoonLake Immunotherapeuti are related but not identical, and they can diverge across cycles. For MoonLake Immunotherapeuti, key inputs include a P/B ratio of 4.04, and ROE of -60.78%. By contrast, market price reflects the level where buyers and sellers transact.